In The News Posted September 6, 2019 Share Posted September 6, 2019 NEW YORK, Sept. 6, 2019 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Nektar Therapeutics from February 15, 2019 through August 8, 2019, inclusive (the "Class Period") of the important October 18, 2019 lead plaintiff deadline in... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.